Price $13.01 |
Market Cap
2.99B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
15.4
|
P/B
2.36
|
P/S
5.83
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
17.3
|
Op. Cash Flow
235.3K
|
FCF
0.5
|
|
Op. Margin
55.50%
|
Net Margin
41.90%
|
ROE
19.70%
|
ROI
13.50%
|
|
ROA
15.60%
|
EPS Growth
-20.00%
|
Current Ratio
7.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Capricor Therapeutics Inc (CAPR) | $5.26 | - | - | 109.2M | Strong Buy |
| Novo Integrated Sciences Inc (NVOS) | $1.74 | - | - | 57.1M | Strong Buy |
| Clearside Biomedical Inc (CLSD) | $1.50 | - | - | 99.2M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.19 | - | - | 152.2M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.50 | - | - | 104.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
